Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Endocrinology | Ophthalmology | Family Medicine
Clinical Trials: Diabetic Retinopathy
A listing of clinical trials currently looking for volunteers to enroll in Diabetic Retinopathy studies. Click on the closest city to find more detailed information on a research study in your area.
Arizona
Mesa : Barnet Dulaney Perkins Eye Center
Computer Detection of Diabetic Retinopathy Compared to Clinical Examination
Phoenix : Barnet Dulaney Perkins Eye Center
Computer Detection of Diabetic Retinopathy Compared to Clinical Examination
Phoenix : Retina Consultants of Arizona
PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)
Phoenix : Retinal Consultants of AZ
Prompt Panretinal Photocoagulation Versus Ranibizumab+Deferred Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
California
Beverly Hills : Retina-Vitreous Associates
PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)
Loma Linda : Loma Linda University Health Care, Dept. of Ophthalmology
Prompt Panretinal Photocoagulation Versus Ranibizumab+Deferred Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
Los Angeles : Jules Stein Eye Institute, Dept. of Ophthalmology, David Geffen School of Medicine at UCLA
Rapid, Non-invasive, Regional Functional Imaging of the Retina. (Diabetic Retinopathy Diagnosis Device)
Palm Springs : Southern California Desert Retina Consultants, MC
Prompt Panretinal Photocoagulation Versus Ranibizumab+Deferred Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
Sacramento : Retinal Consultants Medical Group, Inc.
PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)
View More »
Santa Barbara : California Retina Consultants
Prompt Panretinal Photocoagulation Versus Ranibizumab+Deferred Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
Torrance : Retina Macula Institute
Ozurdex for Treatment of Recalcitrant Diabetic Macular Edema
Walnut Creek : Bay Area Retina Associates
Prompt Panretinal Photocoagulation Versus Ranibizumab+Deferred Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
Connecticut
Trumbull : New England Retina Associates
Prompt Panretinal Photocoagulation Versus Ranibizumab+Deferred Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
Florida
Clearwater : Retina Vitreous Associates of Florida
Dosing Study of Ranibizumab for Diabetic Retinal and Macular Edema
Fort Lauderdale : Retina Group of Florida
Evaluation of the Precision of the Microperimetry Function of the Spectral OCT/SLO
Fort Myers : Retina Consultants of Southwest Florida
Prompt Panretinal Photocoagulation Versus Ranibizumab+Deferred Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
Lakeland : Central Florida Retina Institute
Prompt Panretinal Photocoagulation Versus Ranibizumab+Deferred Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
Ocala : Ocala Eye Retina Consultants
Prompt Panretinal Photocoagulation Versus Ranibizumab+Deferred Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
View More »
Plantation : Fort Lauderdale Eye Institute
Prompt Panretinal Photocoagulation Versus Ranibizumab+Deferred Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
St. Petersburg : Retina Vitreous Associates of Florida
Dosing Study of Ranibizumab for Diabetic Retinal and Macular Edema
Venice : Retina Associates of Sarasota
Prompt Panretinal Photocoagulation Versus Ranibizumab+Deferred Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
Winter Haven : Center for Retina and Macular Disease
PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)
Georgia
Augusta : Southeast Retina Center, P.C.
Prompt Panretinal Photocoagulation Versus Ranibizumab+Deferred Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
Illinois
Glenview : North Shore University Health System
Prompt Panretinal Photocoagulation Versus Ranibizumab+Deferred Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
Indiana
Indianapolis : Thomas A. Cuilla, MD, PC at Midwest Eye Institute
PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)
Indianapolis : Raj K. Maturi, M.D., P.C.
Prompt Panretinal Photocoagulation Versus Ranibizumab+Deferred Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
New Albany : John-Kenyon American Eye Institute
Prompt Panretinal Photocoagulation Versus Ranibizumab+Deferred Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
Iowa
Cedar Rapids : Iowa Eye Center
Computer Detection of Diabetic Retinopathy Compared to Clinical Examination
Iowa City : University of Iowa Department of Ophthalmology and Visual Sciences
Computer Detection of Diabetic Retinopathy Compared to Clinical Examination
West Des Moines : Wolfe Eye Clinic
Prompt Panretinal Photocoagulation Versus Ranibizumab+Deferred Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
Kansas
Shawnee Mission : Retina Associates, PA
Evaluation of Ranibizumab in Proliferative Diabetic Retinopathy (PDR) Requiring Vitrectomy
Kentucky
Lexington : Retina and Vitreous Associates of Kentucky
Prompt Panretinal Photocoagulation Versus Ranibizumab+Deferred Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
Paducah : Paducah Retinal Center
Prompt Panretinal Photocoagulation Versus Ranibizumab+Deferred Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
Maryland
Baltimore : Johns Hopkins Unversity
Evaluation of the Precision of the Microperimetry Function of the Spectral OCT/SLO
Baltimore : Elman Retina Group, P.A.
Prompt Panretinal Photocoagulation Versus Ranibizumab+Deferred Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
Massachusetts
Boston : Ophthalmic Consultants of Boston
Impact of Intravitreal Aflibercept Injections on Capillary Non-Perfusion
Rockland : Call EMD Serono Medical Information for information on recruiting sites
Diabetic Retinopathy in HIV Subjects Treated With EGRIFTA®
Worcester : Vitreo-Retinal Associates, PC
Prompt Panretinal Photocoagulation Versus Ranibizumab+Deferred Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
Michigan
Grand Blanc : Retina Vitrous Center
Prompt Panretinal Photocoagulation Versus Ranibizumab+Deferred Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
Missouri
St. Louis : Barnes Retina Institute
Prompt Panretinal Photocoagulation Versus Ranibizumab+Deferred Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
Nebraska
Lincoln : Eye Surgical Associates
Prompt Panretinal Photocoagulation Versus Ranibizumab+Deferred Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
New Hampshire
Portsmouth : Eyesight Ophthalmic Services, PA
PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)
New Jersey
Toms River : Retina Vitreous Center
PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)
New York
New York : The New York Eye and Ear Infirmary/Faculty Eye Practice
Prompt Panretinal Photocoagulation Versus Ranibizumab+Deferred Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
Rochester : University of Rochester
Prompt Panretinal Photocoagulation Versus Ranibizumab+Deferred Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
Syracuse : Retina-Vitreous Surgeons of Central New York, PC
Prompt Panretinal Photocoagulation Versus Ranibizumab+Deferred Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
North Carolina
Chapel Hill : University of North Carolina
Prompt Panretinal Photocoagulation Versus Ranibizumab+Deferred Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
Charlotte : Southeast Clinical Research Associates, LLC
PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)
Charlotte : Charlotte Eye, Ear, Nose and Throat Assoc., PA
Prompt Panretinal Photocoagulation Versus Ranibizumab+Deferred Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
Ohio
Beachwood : Retina Associates of Cleveland, Inc.
Prompt Panretinal Photocoagulation Versus Ranibizumab+Deferred Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
Oregon
Portland : Casey Eye Institute
Prompt Panretinal Photocoagulation Versus Ranibizumab+Deferred Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
Portland : Retina Northwest, PC
Prompt Panretinal Photocoagulation Versus Ranibizumab+Deferred Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
Pennsylvania
Hershey : Penn State College of Medicine
Prompt Panretinal Photocoagulation Versus Ranibizumab+Deferred Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
Lancaster : Family Eye Group
Prompt Panretinal Photocoagulation Versus Ranibizumab+Deferred Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
Pittsburg : Retina Vitrous Consultants
Prompt Panretinal Photocoagulation Versus Ranibizumab+Deferred Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
Pittsburgh : Neuro Kinetics Inc.
Rapid, Non-invasive, Regional Functional Imaging of the Retina. (Diabetic Retinopathy Diagnosis Device)
South Carolina
Columbia : Carolina Retina Center
Prompt Panretinal Photocoagulation Versus Ranibizumab+Deferred Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
South Dakota
Rapid City : Black Hills Regioinal Eye Institute
PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)
Tennessee
Kingsport : Southeastern Retina Associates, PC
Prompt Panretinal Photocoagulation Versus Ranibizumab+Deferred Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
Knoxville : Southeastern Retina Associates, P.C.
Prompt Panretinal Photocoagulation Versus Ranibizumab+Deferred Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
Texas
Austin : Retina Research Center
Prompt Panretinal Photocoagulation Versus Ranibizumab+Deferred Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
Austin : Austin Retina Associates
Prompt Panretinal Photocoagulation Versus Ranibizumab+Deferred Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
Dallas : Texas Retina Associates
Prompt Panretinal Photocoagulation Versus Ranibizumab+Deferred Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
Houston : Retina Consultants of Houston
Computer Detection of Diabetic Retinopathy Compared to Clinical Examination
Houston : Robert Cizik Eye Clinic - University of Texas Houston
Computer Detection of Diabetic Retinopathy Compared to Clinical Examination
View More »
Houston : Retinal Consultants of Houston
PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)
Houston : Baylor Eye Physicians and Surgeons
Prompt Panretinal Photocoagulation Versus Ranibizumab+Deferred Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
Houston : Retina and Vitreous of Texas
Prompt Panretinal Photocoagulation Versus Ranibizumab+Deferred Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
Lubbock : Texas Retina Associates
Prompt Panretinal Photocoagulation Versus Ranibizumab+Deferred Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
McAllen : Valley Retina Institute
Evaluation of the Precision of the Microperimetry Function of the Spectral OCT/SLO
McAllen : Valley Retina Institute
PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)
McAllen : Valley Retina Institute
Prompt Panretinal Photocoagulation Versus Ranibizumab+Deferred Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
San Antonio : Retinal Consultants of San Antonio
PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)
San Antonio : Retinal Consultants of San Antonio
Prompt Panretinal Photocoagulation Versus Ranibizumab+Deferred Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
Washington
Seattle : University of Washington Medical Center
Prompt Panretinal Photocoagulation Versus Ranibizumab+Deferred Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
Spokane : Spokane Eye Clinic
Prompt Panretinal Photocoagulation Versus Ranibizumab+Deferred Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
Tacoma : Chous Eye Care Associates
Diabetes Visual Function Supplement Study
Wisconsin
Milwaukee : Medical College of Wiconsin
Prompt Panretinal Photocoagulation Versus Ranibizumab+Deferred Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
Denmark
Glostrup : GSK Investigational Site
A Phase 2 Clinical Study to Investigate Effects of Darapladib in Subjects With Diabetic Macular Edema
Germany
Freiburg : GSK Investigational Site
A Phase 2 Clinical Study to Investigate Effects of Darapladib in Subjects With Diabetic Macular Edema
Koeln : GSK Investigational Site
A Phase 2 Clinical Study to Investigate Effects of Darapladib in Subjects With Diabetic Macular Edema
Leipzig : GSK Investigational Site
A Phase 2 Clinical Study to Investigate Effects of Darapladib in Subjects With Diabetic Macular Edema
Muenster : GSK Investigational Site
A Phase 2 Clinical Study to Investigate Effects of Darapladib in Subjects With Diabetic Macular Edema
Ulm : GSK Investigational Site
A Phase 2 Clinical Study to Investigate Effects of Darapladib in Subjects With Diabetic Macular Edema
India
Kochi : Amrita
A Safety and Efficacy Study of Vitreosolve® for Non-Proliferative Diabetic Retinopathy Subjects
Vizag : LVPEI
A Safety and Efficacy Study of Vitreosolve® for Non-Proliferative Diabetic Retinopathy Subjects
Israel
Jerusalem : Hadassah Ein Kerem Medical Center
PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)
Petah Tiqva : Rabin Medical Center
PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)
Rehovot : Kaplan Medical Center
PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)
Tel Aviv : Tel Aviv Sourasky Medical Center
PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)
Zerifin : Assaf Harofe Medical Center
PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)
Italy
Milano : GSK Investigational Site
A Phase 2 Clinical Study to Investigate Effects of Darapladib in Subjects With Diabetic Macular Edema
Mexico
Mexico City : Conde De Valenciana
A Safety and Efficacy Study of Vitreosolve® for Non-Proliferative Diabetic Retinopathy Subjects
Monterrey : Hidalgo
A Safety and Efficacy Study of Vitreosolve® for Non-Proliferative Diabetic Retinopathy Subjects
San Lucas : La Ceguera
A Safety and Efficacy Study of Vitreosolve® for Non-Proliferative Diabetic Retinopathy Subjects
Netherlands
Rotterdam : GSK Investigational Site
A Phase 2 Clinical Study to Investigate Effects of Darapladib in Subjects With Diabetic Macular Edema
Switzerland
Zurich : Department of Ophthalmology, Triemli Hospital Zurich
A Pilot Study on the Effects of ILARIS® on Patients With Proliferative Diabetic Retinopathy (PDRP)
United Kingdom
Ayr : Novartis Investigative Site
Ranibizumab Treatment of Diabetic Macular Oedema With Bimonthly Monitoring After a Phase of Initial Treatment
Birmingham : Novartis Investigative Site
Ranibizumab Treatment of Diabetic Macular Oedema With Bimonthly Monitoring After a Phase of Initial Treatment
Cardiff : Novartis Investigative Site
Ranibizumab Treatment of Diabetic Macular Oedema With Bimonthly Monitoring After a Phase of Initial Treatment
Colchester : Novartis Investigative Site
Ranibizumab Treatment of Diabetic Macular Oedema With Bimonthly Monitoring After a Phase of Initial Treatment
Devon : Novartis Investigative Site
Ranibizumab Treatment of Diabetic Macular Oedema With Bimonthly Monitoring After a Phase of Initial Treatment
View More »
Dunfermline : Novartis Investigative Site
Ranibizumab Treatment of Diabetic Macular Oedema With Bimonthly Monitoring After a Phase of Initial Treatment
Hull : Novartis Investigative Site
Ranibizumab Treatment of Diabetic Macular Oedema With Bimonthly Monitoring After a Phase of Initial Treatment
Liverpool : Novartis Investigational Site
Ranibizumab Treatment of Diabetic Macular Oedema With Bimonthly Monitoring After a Phase of Initial Treatment
London : Moorfields Eye Hospital
Ranibizumab in Diabetic Vitrectomy
London : Novartis Investigative Site
Ranibizumab Treatment of Diabetic Macular Oedema With Bimonthly Monitoring After a Phase of Initial Treatment
Norfolk : Novartis Investigative Site
Ranibizumab Treatment of Diabetic Macular Oedema With Bimonthly Monitoring After a Phase of Initial Treatment
Rugby : Novartis Investigative Site
Ranibizumab Treatment of Diabetic Macular Oedema With Bimonthly Monitoring After a Phase of Initial Treatment
Uxbridge : Novartis Investigative Site
Ranibizumab Treatment of Diabetic Macular Oedema With Bimonthly Monitoring After a Phase of Initial Treatment
York : Novartis Investigative Site
Ranibizumab Treatment of Diabetic Macular Oedema With Bimonthly Monitoring After a Phase of Initial Treatment
